Associate Professor Dr. Gamil G. S. Zeedan obtained Ph.D. Virology ,Cairo University Egypt , MVSCs Virology, Cairo University. BVSCs , Cairo University . 2015 up to date Assistant Professor of Microbiology and Virology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia,2014 -2015 Associate Professor of Microbiology at National Research Center Ministry of High Education - Cairo Egypt -Cairo Egypt, .10-2013 Assistant Professor of Microbiology at Faculty of Medicine and Applied Medical Sciences –Northern Border University (NBU)- KSA) for 3acdemic years 2007- 2010,Assistant Researcher at National Research Center- Ministry of High Education - Cairo Egypt. He teaching the following curriculum,Medical Microbiology and Virology, Diagnostic Microbiology ,Clinical Rotation of Microbiology and Clinical Rotation Immunology & Virology. 2015- up-to-date Microbiology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia . 2010-52013 Microbiology in faculty of Medicine and Applied medical Sciences - Northern Border University, Saudi Arabia. Participate in teaching Medical Microbiology ( Virology ) MICM 311 courses for 3rd-year Medical students (3 hours/week).Participate in teaching Diagnostic Microbiology

Microbiology and Virology

R. P. Iyer, (Kris), Ph.D., FRSC is the co-founder and Chief Scientific Officer of Spring Bank Pharmaceuticals. He has more than 25 years’ experience in Biotechnology industry in drug discovery and development in diverse therapeutic areas including antivirals, inflammation and immune-oncology. Kris is a leading innovator in the fields of nucleic acid chemistry, bioorganic chemistry and pharmaceutical sciences with over 100 publications and 200 issued, as well as, filed US and international patents. Prior to Spring Bank, Kris was the co-founder and VP of Discovery of Origenix Technologies and also served as Associate Director of Antisense Discovery at Hybridon, Inc. He currently serves on the Board of Directors of Spring Bank Pharmaceuticals and is a member of the Scientific Advisory Board of Oligomerix, Inc., NY.

Cancer Immunology

Dr. Jerald C. Sadoff is currently the Head of Early Development of the Crucell Vaccine Institute which is the Center of Excellence for Vaccine Development for Johnson & Johnson Companies Worldwide. Dr. Sadoff has spent his entire career developing vaccines against a large number of bacterial, viral and parasitic diseases, 11 of which have been licensed for human use and several currently are in Phase IIB and Phase III clinical trials. He currently serves on several IPCAVD Scientific Advisory Boards for NIH sponsored HIV vaccine efforts and is on the NIAID AIDS Vaccine Research Working Group. Over the last 35 years, he has authored over 350 articles, book chapters, and abstracts and has 18 issued patents

Vaccine Development

Pierre A. MORGON is Chief Executive Officer of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement, an evergreen investment structure focused on medical devices, in vitro diagnostics and patient management services. He is also Chairman of the Board of Virometix since January 2017, a company developing proprietary synthetic nanoparticle platform in vaccines and immunotherapeutic drugs for viral diseases and cancer, as well as Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, and Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedicated to developing nasal vaccines. He joined the board of Virometix as chairman in January 2017

Vaccines and Immunotherapeutic drugs for Viral diseases and Cancer

Benoit Tano, M.D. is a specialist, pioneer, and the Minneapolis area’s foremost expert in the field of Integrative Immunity. Dr. Tano is the founder of Integrative Immunity Health System, PC located in Edina, Minnesota. He is Johns Hopkins-fellowship trained in allergy and clinical immunology and authored the number one bestselling book, The Layman’s Guide to Integrative Immunity (2016). He combines his vast expertise in allergy and clinical immunology and in hormone imbalance syndrome to treat the root causes of 21st-century chronic diseases.

Clinical Immunology

Professor Andrzej K. Siwicki, VMD, Ph.D., DSc is a Head of Department Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury and Department of Pathology and Immunology IFI in Olsztyn, Poland. He is author of over 500 original papers in reputed journals and about 200 scientific communications (index-h 32, index of citation: 4502). His fields of interest are modulation of defence mechanisms and protection against diseases by natural and synthetic products in animals, influence of pollutants on the cell-mediated immunity and restoration of immunity after suppression induced by xenobiotics. Developed a new possibility in the comparative immunotoxicology for control of effect of xenobiotics and pharmaceutical products on the defence mechanisms and protection against diseases. He attended scientific missions in USA, Japan, France and Israel, was a co-ordinator of USDA and FAO projects and he is professor conferring of 14 PhDs and 4 DSc.

Microbiology and Clinical Immunology

1998-2003 Member of the Institut Universitaire de France Junior, then Honorary position 1998-2000 Senior Scientist at the Mind Body Institute of Harvard Medical School, USA 31/05/1995 Habilitation for directing research in Natural Sciences, University Lille 1 3/02/1993 Ph.D. in Life Science and Health, University Lille 1

Immunology

Prof. Dr. Ignat Ignatov was born on January 1, 1963 in the town of Teteven, Bulgaria. Тhe family Ignatov is from village of Gradina, region of Pleven, Bulgaria. In 1976 descrebes a phenomenon in which little apertures act like optic lenses. In 1989 Ignatov majored in physics from “Kliment Ohridski” Sofia University with master degree. In the same year he began his professional work in the sphere of medical biophysics. In 1996 he founded the Scientific and Research Center of Medical Biophysics (SRCMB) of which he is also an owner. Prof. Dr. Ignat Ignatov was a consultant of the National Center of Public Health (NCPH) at the Ministry of Health until 2003. The Bulgarian scientist is involved in research projects for the study of biophysical and medical effects in the application of alternative methodics for the influencing of human health. Bulgaria has a Health Act, which authorizes the practice of non-conventional (alternative) methodics. Trainings are carried out. From 2007 Ignat Ignatov is honorable doctor in European Academy of Natural Sciences (Germany). From 2013 he is Doctor of Science and Professor in The Russian Academy for Natural History. Prof. Ignatov is Chief Editor of two US journals. The first is Journal of Medicine, Physiology and Biophysics. The second is Journal of Health, Medicine and Nursing. The Bulgarian scientist is editor in chief in European Journal of Molecular Biotechnology, European Journal of Medicine - international bilingual scientific Journal and Research & Reviews in Biosciences.

Medicine, Physiology and Biophysics

He graduated from Hacettepe University Faculty of Medicine in 1990. He completed his specialist education in Hacettepe University Faculty of Medicine Internal Medicine Department in 1995 and his branch of Medical Oncology Unit in 1999. Associate Professor in 2000, Professor in 2007. Between 2004 and 2006, she worked as a guest lecturer at the MD Anderson Cancer Center in Houston, Texas, USA to study breast cancer. Hacettepe University Institute of Health Sciences in 2013 and Hacettepe University Cancer Institute in 2013-2016 and Hacettepe University Internal Medicine Department and Medical Oncology Department in 2013-2015.

Oncology

Sr. Research Associate at University of Texas Health Science Center at Houston Former Research Assistant at Baylor College of Medicine Former Research Assistant at New York Medical College

Epidemiolgy, Biochemistry

Dr. Luiz Werber-Bandeira is a physician with emphasis in Clinical Immunology, head of Clinical Immunology at the Santa Casa da Misericórdia Hospital and responsible for all the professional team that compose the clinical body of Imunoderm, in the Botafogo neighborhood and Ilha do Governador, Rio de January. For 36 years in the profession, he has done Post-Doctorate in Immuno-Genetics from the Oswaldo Cruz Foundation (FioCruz-RJ), a master's degree and a PhD from the Federal University of Rio de Janeiro (UFRJ). He is coordinator of the Postgraduate Course in Immunology and Clinical and Laboratory Allergy, organizer responsible for the Research Line of the Clinical and Experimental Immunology Unit of the Santa Casa da Misericórdia in Rio de Janeiro, as well as a professor who participates in the line of research in PhotoDermatology and Immunology of UFRJ.

PhotoDermatology and Immunology

Dr. Ahmed Shoker was born in Egypt, graduated from the University of Alexandria, Egypt and moved to Canada in 1981. He received his training in general medicine at the University of British Columbia, Vancouver, Canada. He received his training in nephrology and transplantation at the University of Toronto where he received his fellowship training in transplantation between 1987 and1990. He then moved to the University of Saskatchewan. Currently, he is a Professor of Medicine and Nephrology at the University of Saskatchewan. He is the Medical Director of the provincial Transplant Program. His research interests include clinical trials and basic research in the field of immunosuppression and inflammation.

His current interest is the relationship between cardiovascular disease risk factors and inflammatory markers before and after kidney transplantation

As a Professor of Clinical and Chemical Pathology with an MD degree from the Faculty of Medicine, Cairo University and as the current Head of the Electron Microscopic Research Department in the Theodor Bilharz Research Institute , a medical research institution affiliated to the Egyptian Ministry of Higher Education and Scientific Research I focus my research on the role of immune cells in combating hepatic diseases caused by helminthic (schistosomiasis), bacterial or viral infections (hepatitis virus ) using electron microscopy and immunoelectron microscopy to visualize cellular changes accompanying such diseases. I was involved in scientific cooperative research with German and French institutions and I am very open to different cultures. I speak fluent English, German, French, and Arabic.

I focus my research on the role of immune cells in combating hepatic diseases caused by helminthic (schistosomiasis), bacterial or viral infections (hepatitis virus ) using electron microscopy and immunoelectron microscopy to visualize cellular changes accompanying such diseases.

Qingxian Lu received his Bachelor's degree from Shandong University, Master's from Peking Union Medical College, Beijing, and Ph. D.The University of Texas.

His interests are focused on elucidating molecular mechanisms of three closely-related receptor tyrosine kinases, called Tyro3, Axl and Mertk (TAM), in the regulation of phagocytic activity in professional and non-professional phagocytes, particularly in the retinal pigmental epithelium cells in the eye. Phagocytic clearance of the spent photoreceptor distal outer segment (OS) tips by the retinal pigmental epithelium (RPE) cells is essential to maintain photoreceptor homeostasis. Failure of RPE phagocytosis of the OS leads to retinitis pigmentosa (RP). Mutation in the Mertk receptor tyrosine kinase causes photoreceptor degeneration. To understand the molecular role of Mertk in phagocytosis, we have used Mertk mutated RPE cells as a model to identify Mertk downstream target genes or signaling molecules that are involved in regulation of the phagocytic events.